July 11, 2023
FDA: Class I recall of Megadyne’s Mega 2000, Mega Soft reusable patient return electrodes
Editor's Note
The Food and Drug Administration (FDA), on July 11, identified the recall by Megadyne of its Mega 2000 and Mega Soft reusable patient return electrodes as Class I, the most serious.
The recall was initiated after Megadyne received reports of pediatric and adult patients receiving burn injuries during surgical procedures in which monopolar electrosurgical instruments were used.
The company reports 63 injuries and no deaths related to this issue. Distribution dates were March 11, 2021, to May 9, 2023.
Free Daily News
- Healthcare M&A faces tighter review as FTC retains guidelines
- Healthcare giants prioritize shareholder payouts over patient care
- Texas abortion ban linked to spike in pregnancy complications, maternal death
- AI streamlines documentation, frees time for nurses at Cedars-Sinai surgical unit
- Study identifies potential non-surgical treatment for inguinal hernias
- Rural hospital closures remain a growing concern despite slight financial improvement
- Session: Hoisting the Sails—Winning Strategies for Growing Service Lines in an ASC
- Session: Riding the Wave—Considerations to Making Anesthesia Profitable in Today's Labor Market
- Session: Surfs Up—Rolling Out the OAS CAHPS Survey
- Montana legislators' prior authorization reform push mirrors national trends
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement